Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer
byUniversity of Texas M. D. Anderson Cancer CenterOncoprint of targeted somatic gene variants of tumors in patients with anaplastic thyroid cancer (atc) enrolled in cohorts 1 to 3. Credit:
Updated on: November 11,2024
0

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer
byUniversity of Texas M. D. Anderson Cancer CenterOncoprint of targeted somatic gene variants of tumors in patients with anaplastic thyroid cancer (atc) enrolled in cohorts 1 to 3. Credit:
Updated on:November 11,2024
0
